Top Companies in Automated Immunoassay Analyzers Market | Research Report by Vantage Market Research
The market for automated immunoassay analyzers is expected to develop due to the growing trend toward lab automation and the rising occurrence of infectious disorders.
Coralia.Joe
The global Automated Immunoassay Analyzers market is valued at USD 10.13 Billion in 2021 and is projected to attain a value of USD 28.15 Billion by 2028 at a CAGR of 15.6% during the forecast period, 2022–2028. The rising number of people encountering severe conditions has initiated a requirement for automated immunoassay analyzer testing facilities. This technique is considered to have a moderate risk of complications and hence when compared to others and proves to be a better solution. As a consequence of the growing population in cities and modern lifestyles, an outbreak of various diseases is observed. The majority of the population is suffering from diseases such as diabetes, heart disease, cancer, and others. A recent study shows that around 30 million Americans are facing heart diseases every year and 45% of them result in fatality. The demand for automated immunoassay analyzers in laboratories and hospitals has been increasing a lot lately, as they ensure the accuracy of reports, simultaneously making the lab procedures more efficient. The high sensitivity of automated immunoassay analyzers makes them an apt asset to the medical staff during these onerous times, as these instruments can aid in precisely detecting the infected population.
Automated immunoassay analyzer testing is a growing area of interest for diagnosing a number of neurological, cardiovascular, arthritis and other diseases. The biggest disadvantages of the automated immunoassay analyzer are its high cost and presence in fewer healthcare facilities. The cost for an automated immunoassay analyzer is higher owing to its management of a patient’s hospital setting, infrastructure, and risk analysis. These make it costly and hence to some extent might hinder the Market Growth.
Following are the top 10 leading companies in the Automated Immunoassay Analyzers market:
|
Company Name |
Revenue in USD |
|
$17 Billion |
|
$43 Billion |
|
$3 Billion |
|
$2 Billion |
|
$67 Billion |
|
$3 Billion |
|
$653 Million |
|
$2 Billion |
|
$298 Million |
|
$40 billion |
Siemens Healthineers AG is a German multinational company founded in 2015. It is the parent company for several medical technology companies and is headquartered in Erlangen, Germany. The company dates its early beginnings in 1847 to a small family business in Berlin, co-founded by Werner von Siemens. In 2020, the company generated revenue of USD 1,446 Million and has 66,000 (2021) employees working across the globe. The company is listed as SHL (ETR) on the German Stock exchange. The company has various subsidiaries such as Varian Medical Systems, Corindus, Inc., and various others.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs. The company sells medical devices, diagnostics, branded generic medicines and nutritional products. Among its well-known products across the medical devices, diagnostics, and nutrition product divisions are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France. A global leader in in-vitro diagnostics for more than 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improving public health worldwide. The company provides diagnostic solutions (reagents, instruments, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California. The company is based in Hercules, California, and has operations worldwide. The company's life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.
Roche is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world and the leading provider of cancer treatments globally. The company controls the American biotechnology company Genentech, which is a wholly-owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States-based companies Ventana and Foundation Medicine. is organized into five major business areas: Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics and Roche Tissue Diagnostics. All business areas except Roche Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers. Applied Science targets research settings in academia and pharmaceutical and biotechnology industries.
Beckman Coulter Inc. is a Danaher Corporation company that develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. It is operating in two industries: Diagnostics and Life Sciences. With a history of more than 80 years, the company helps healthcare and laboratory professionals, pharmaceutical and biotechnology companies, universities, medical schools, and research institutions worldwide. The company is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. The company's diagnostic systems are used in complex biomedical testing and are found in hospitals, reference laboratories and physician office settings around the globe.
Radiometer is a Danish multinational company that develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and related IT management systems. The company was founded in 1935 in Copenhagen, Denmark by Børge Aagaard Nielsen and Carl Schrøder. It has over 3,200 employees and direct representation in more than 32 countries. The company provides powerful acute care diagnostic solutions based on the belief that a seamless relationship between people and technology is crucial.
Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing. Ortho serves two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood. The information gained from diagnostic tests is responsible for 70% of all medical decisions. The company provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate and reliable.
A global market leader within the Vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. With offices and distribution in over 145 countries, the company offers customers improved efficiency, quality, cost-effectiveness and flexibility. The company is committed to revolutionising healthcare on a global scale. The company is advancing cutting-edge science and technologies that hold the key to groundbreaking improvements in diagnostics and healthcare. Through a heavily committed research and development programme, the company continues to offer revolutionary products and solutions specifically designed to provide more efficient, higher quality, and reliable diagnostics in the widest variety of laboratory settings.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. The company's mission is to enable its customers to make the world healthier, cleaner and safer. The company supports their customers to accelerate life sciences research, solve complex analytical challenges, increase productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies. The company's global team delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Get a Free Sample Here @ https://www.vantagemarketresearch.com/automated-immunoassay-analyzers-market-1314/request-sample
For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, an in-depth analysis of key players, Development opportunities, Sales, Revenue Forecast.
